Sorry, you need to enable JavaScript to visit this website.
Skip to main content
EXPERTISE

Location Settings

North America

US -  Boston
US -  San Francisco

Oceania

NZ -  New Zealand
AU -  Brisbane
AU -  Melbourne
AU -  Sydney

Asia

TH -  Bangkok
CN -  Taipei City
KR -  Seoul
PH -  Metro Manila
MY -  Kuala Lumpur
IN -  Bangalore
CN -  Shanghai
CN -  Hong Kong

GLOBAL

English

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

North America

US -  Boston
US -  San Francisco

Oceania

NZ -  New Zealand
AU -  Brisbane
AU -  Melbourne
AU -  Sydney

Asia

TH -  Bangkok
CN -  Taipei City
KR -  Seoul
PH -  Metro Manila
MY -  Kuala Lumpur
IN -  Bangalore
CN -  Shanghai
CN -  Hong Kong

GLOBAL

English

Oncology CRO services

Worth Sharing?

Landscape of Oncology in Asia-Pacific

Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.

For these reasons we observed a fast-growing interest from biotechnology companies to include the Asia-Pacific region for their Oncology drug development. The yearly activity growth of biotechnology companies in Oncology and Immuno-Oncology was estimated at around 40% in the Asia-Pacific region between 2016 and 2018.

Because of lower risk of competing trials and high engaged sites and investigators, Oncology clinical trials involving the Asia-Pacific region have historically recruited patients faster than other regions. For Industry-sponsored Oncology clinical studies initiated in 2018, trials involving the Asia-Pacific region showed a lower median enrolment duration (20% faster) compared with Oncology studies globally.

Oncology CRO services and Immuno-Oncology CRO services.

Biotechs looking for Oncology CRO services are coming to Asia-Pacific and increasingly partnering with regional CRO specialists with a similar fit in terms of culture and flexibility. About half of Novotech’s projects are in Oncology and Immuno-Oncology. Novotech has built teams with deep expertise in Oncology and Immuno-Oncology and strong connections with Oncology key opinion leaders and sites in the Asia-Pacific region.

Novotech has build solid and long-lasting relationships with investigators allowing to quickly identify and recommend the most appropriate sites for your study in Oncology. Site selection is essential to the success of clinical studies in Oncology.

Over the last 25 years, Novotech has partnered with numerous biotechnology companies and completed hundreds of projects in Oncology. Novotech has consistently provided high quality Oncology CRO services through a  flexible approach that suits the need of small and medium biotechnology companies.


Novotech experience in Oncology and Immuno-Oncology.

Novotech has conducted over a hundred trials in Oncology including these Oncology and Immuno-Oncology indications:

Solid tumour clinical trials

  • Bladder Cancer
  • Breast cancer
  • Cervical cancer
  • Bladder Cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Gastric Cancer
  • Glioblastoma
  • HCC, Hepatocellular Carcinoma
  • Head & neck cancer
  • Melanoma
  • NSCLC, non-small cell Lung Cancer
  • Other
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate ca
  • Renal Cancer
  • Sarcoma
  • SCLC, Small Cell Lung Cancer
  • Other Solid tumours

Haematological malignancies clinical trials

  • Chronic lymphocytic leukemia (CLL)
  • Acute myeloid leukemia (AML)
  • Lymphoma
  • Myeloma
  • Chronic Myelomonocytic Leukemia
  • Non Hodgkin's lymphoma